Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Slobodan Devic is active.

Publication


Featured researches published by Slobodan Devic.


Medical Physics | 2005

Precise radiochromic film dosimetry using a flat-bed document scanner

Slobodan Devic; J Seuntjens; E Sham; Ervin B. Podgorsak; C. Ross Schmidtlein; Assen S. Kirov; Christopher G. Soares

In this study, a measurement protocol is presented that improves the precision of dose measurements using a flat-bed document scanner in conjunction with two new GafChromic® film models, HS and Prototype A EBT exposed to 6MV photon beams. We established two sources of uncertainties in dose measurements, governed by measurement and calibration curve fit parameters contributions. We have quantitatively assessed the influence of different steps in the protocol on the overall dose measurement uncertainty. Applying the protocol described in this paper on the Agfa Arcus II flat-bed document scanner, the overall one-sigma dose measurement uncertainty for an uniform field amounts to 2% or less for doses above around 0.4Gy in the case of the EBT (Prototype A), and for doses above 5Gy in the case of the HS model GafChromic® film using a region of interest 2×2mm2 in size.


Medical Physics | 2004

Dosimetric properties of improved GafChromic films for seven different digitizers

Slobodan Devic; J Seuntjens; Gyorgy Hegyi; Ervin B. Podgorsak; Christopher G. Soares; Assen S. Kirov; Imad Ali; Jeffrey F. Williamson; Angel Elizondo

Two recently introduced GafChromic film models, HS and XR-T, have been developed as more sensitive and uniform alternatives to GafChromic MD-55-2 film. The HS model has been specifically designed for measurement of absorbed dose in high-energy photon beams (above 1 MeV), while the XR-T model has been introduced for dose measurements of low energy (0.1 MeV) photons. The goal of this study is to compare the sensitometric curves and estimated dosimetric uncertainties associated with seven different GafChromic film dosimetry systems for the two new film models. The densitometers tested are: LKB Pharmacia UltroScan XL, Molecular Dynamics Personal Densitometer, Nuclear Associates Radiochromic Densitometer Model 37-443, Photoelectron Corporation CMR-604, Laser Pro 16, Vidar VXR-16, and AGFA Arcus II document scanner. Pieces of film were exposed to different doses in a dose range from 0.5 to 50 Gy using 6 MV photon beam. Functional forms for dose vs net optical density have been determined for each of the GafChromic film-dosimetry systems used in this comparison. Two sources of uncertainties in dose measurements, governed by the experimental measurement and calibration curve fit procedure, have been compared for the densitometers used. Among the densitometers tested, it is found that for the HS film type the uncertainty caused by the experimental measurement varies from 1% to 3% while the calibration fit uncertainty ranges from 2% to 4% for doses above 5 Gy. Corresponding uncertainties for XR-T film model are somewhat higher and range from 1% to 5% for experimental and from 2% to 7% for the fit uncertainty estimates. Notwithstanding the significant variations in sensitivity, the studied densitometers exhibit very similar precision for GafChromic film based dose measurements above 5 Gy.


Medical Physics | 2006

Accurate skin dose measurements using radiochromic film in clinical applications

Slobodan Devic; J Seuntjens; Wamied Abdel-Rahman; Michael D.C. Evans; Marina Olivares; Ervin B. Podgorsak; Té Vuong; Christopher G. Soares

Megavoltage x-ray beams exhibit the well-known phenomena of dose buildup within the first few millimeters of the incident phantom surface, or the skin. Results of the surface dose measurements, however, depend vastly on the measurement technique employed. Our goal in this study was to determine a correction procedure in order to obtain an accurate skin dose estimate at the clinically relevant depth based on radiochromic film measurements. To illustrate this correction, we have used as a reference point a depth of 70 micron. We used the new GAFCHROMIC dosimetry films (HS, XR-T, and EBT) that have effective points of measurement at depths slightly larger than 70 micron. In addition to films, we also used an Attix parallel-plate chamber and a home-built extrapolation chamber to cover tissue-equivalent depths in the range from 4 micron to 1 mm of water-equivalent depth. Our measurements suggest that within the first millimeter of the skin region, the PDD for a 6 MV photon beam and field size of 10 x 10 cm2 increases from 14% to 43%. For the three GAFCHROMIC dosimetry film models, the 6 MV beam entrance skin dose measurement corrections due to their effective point of measurement are as follows: 15% for the EBT, 15% for the HS, and 16% for the XR-T model GAFCHROMIC films. The correction factors for the exit skin dose due to the build-down region are negligible. There is a small field size dependence for the entrance skin dose correction factor when using the EBT GAFCHROMIC film model. Finally, a procedure that uses EBT model GAFCHROMIC film for an accurate measurement of the skin dose in a parallel-opposed pair 6 MV photon beam arrangement is described.


Medical Physics | 2009

Optimizing the dynamic range extension of a radiochromic film dosimetry system

Slobodan Devic; Nada Tomic; Christopher G. Soares; Ervin B. Podgorsak

The authors present a radiochromic film dosimetry protocol for a multicolor channel radiochromic film dosimetry system consisting of the external beam therapy (EBT) model GAFCHROMIC film and the Epson Expression 1680 flat-bed document scanner. Instead of extracting only the red color channel, the authors are using all three color channels in the absorption spectrum of the EBT film to extend the dynamic dose range of the radiochromic film dosimetry system. By optimizing the dose range for each color channel, they obtained a system that has both precision and accuracy below 1.5%, and the optimized ranges are 0-4 Gy for the red channel, 4-50 Gy for the green channel, and above 50 Gy for the blue channel.


International Journal of Radiation Oncology Biology Physics | 2003

Contribution of conformal therapy in the treatment of anal canal carcinoma with combined chemotherapy and radiotherapy: results of a phase II study.

Té Vuong; Slobodan Devic; Paul Belliveau; Thierry Muanza; Gyorgy Hegyi

PURPOSEnTo evaluate the feasibility of delivering conformal radiotherapy (RT) and concurrent chemotherapy without a mandatory break in patients with anal canal carcinoma.nnnMETHODS AND MATERIALSnThirty patients with T2-T4 tumors were treated with a combination of 54 Gy in 30 fractions and two cycles of 5-fluorouracil and mitomycin C. Dose-volume histograms were obtained for bone marrow, small bowel, and skin to compare the conventional technique using the Radiation Therapy Oncology Group standard with our conformal technique.nnnRESULTSnThe mean dose ratio of the conventional compared with the conformal technique for bone marrow, small bowel, and skin was, respectively, 2.1-2.7, 3.0, and 2.0, in favor of the conformal technique. All patients completed their treatment without a treatment break. An incidence of Grade 3 toxicity for bone marrow, bowel, and skin of 13.3%, 3.3%, and 20%, respectively, was observed. With a median follow-up of 33 months, a 4-year local recurrence-free survival rate of 91% was observed.nnnCONCLUSIONnThe results of this study have shown that conformal RT leads to a well-tolerated treatment. The treatment time is shortened to 6 weeks. A significant decrease in the acute toxicity rate suggests that by decreasing the volume factor, conformal RT improves the therapeutic index in patients treated with combined chemotherapy and RT.


Physics in Medicine and Biology | 2005

Dosimetric and microdosimetric study of contrast-enhanced radiotherapy with kilovolt x-rays.

F Verhaegen; Brigitte Reniers; F. DeBlois; Slobodan Devic; J Seuntjens; Dimitre Hristov

Kilovolt x-rays are clearly suboptimal compared to MV photon beams for radiotherapy of deep-seated tumours because of the increased attenuation in tissue, causing a rapid dose fall-off. This picture could change drastically when tumours can be labelled with contrast medium, containing high atomic number elements. This causes a significant dose enhancement to the tumour by exploiting the high cross sections for the photo-electric effect for kV x-rays. In this work, we have investigated the dosimetric and microdosimetric characteristics of kV contrast-enhanced radiation therapy (CERT) for different photon energies, contrast-medium concentrations and types (I and Gd). Two idealized patient treatment plans (head and lung) for irradiation with CT-arc beams were calculated. It is shown that the dose enhancement in tumours can be highly significant (up to about sixfold for realistic 80-120 kVp x-ray spectra and an iodine concentration of 50 mg ml-1) but that dose homogeneity in the tumour depends on photon energy, contrast-medium concentration and type, and irradiation scheme. An attempt to optimize the irradiation scheme is discussed. The microdosimetric study of the dose mean lineal energy shows that radiation quality changes in the contrast-medium-labelled region compared to homogeneous tissue are fairly small and limited to 10%. It is concluded that kV-CERT is a promising radiotherapy technique, provided contrast medium can be delivered reliably to tumours.


Medical Physics | 2007

Absorption spectroscopy of EBT model GAFCHROMIC™ film

Slobodan Devic; N Tomic; Zhiyu Pang; J Seuntjens; Ervin B. Podgorsak; Christopher G. Soares

The introduction of radiochromic films has solved some of the problems associated with conventional 2D radiation detectors. Their high spatial resolution, low energy dependence, and near-tissue equivalence make them ideal for measurement of dose distributions in radiation fields with high dose gradients. Precise knowledge of the absorption spectra of these detectors can help to develop more suitable optical densitometers and potentially extend the use of these films to other areas such as the measurement of the radiation beam spectral information. The goal of this study is to present results of absorption spectra measurements for the new GAFCHROMIC film, EBT type, exposed to 6 MV photon beam in the dose range from 0 to 6 Gy. Spectroscopic analysis reveals that in addition to the two main absorption peaks, centered at around 583 and 635 nm, the absorption spectrum in the spectral range from 350 to 800 nm contains six more absorption bands. Comparison of the absorption spectra reveals that previous HD-810, MD-55, as well as HS GAFCHROMIC film models, have nearly the same sensitive layer base material, whereas the new EBT model, GAFCHROMIC film has a different composition of its sensitive layer. We have found that the two most prominent absorption bands in EBT model radiochromic film do not change their central wavelength position with change in a dose deposited to the film samples.


Medical Physics | 2006

Sensitivity of linear CCD array based film scanners used for film dosimetry.

Slobodan Devic; Yi-Zhen Wang; N Tomic; Ervin B. Podgorsak

Film dosimetry is commonly performed by using linear CCD array transmission optical densitometers. However, these devices suffer from a variation in response along the detector array. If not properly corrected for, this nonuniformity may lead to significant overestimations of the measured dose as one approaches regions close to the edges of the scanning region. In this note, we present measurements of the spatial response of an AGFA Arcus II document scanner used for radiochromic film dosimetry. Results and methods presented in this work can be generalized to other CCD based transmission scanners used for film dosimetry employing either radiochromic or radiographic films.


Medical Physics | 2008

Influence of focal spot on characteristics of very small diameter radiosurgical beams

E Sham; J Seuntjens; Slobodan Devic; Ervin B. Podgorsak

Percentage depth dose (PDD) distributions and beam profiles of very small diameter (1.5-5mm) megavoltage radiosurgical beams calculated with Monte Carlo (MC) technique critically depend on the diameter of the circular focal spot used in the simulation: The smaller is the field diameter, the larger is the effect. Thus, in simulations of radiosurgical fields that have diameters of the order of the focal spot size, an accurate focal spot geometry should be used. We used a simplified moving slit technique in conjunction with a diode detector for evaluation of the focal spot size and shape of a megavoltage 6MV linac as well as for determination of the equivalent focal spot diameter of the linac for use in MC simulations. The measured total diode signal contains three components: A direct focal spot signal, a background signal, and an extra-focal radiation signal. A single profile scan of the focal spot signal is Gaussian like in shape, and its full width at half maximum is used to define the focal spot dimension for this scan. The focal spot of our 6MV linac is approximated with a Gaussian circle, and when the geometry of the effective focal spot circle is used in MC simulations, the agreement between MC-calculated and measured PDD distributions as well as beam profiles is good even for radiosurgical fields as small as 1.5mm in diameter. Our results also confirm that matching the penumbral areas of accurately measured large-field beam profiles to the same areas of the MC-calculated beam profiles reliably leads to a realistic effective focal spot size for use in MC simulations of very small diameter beams.


Journal of Applied Clinical Medical Physics | 2005

Advantages of inflatable multichannel endorectal applicator in the neo‐adjuvant treatment of patients with locally advanced rectal cancer with HDR brachytherapy

Slobodan Devic; Té Vuong; Belal Moftah

High‐dose rate endorectal brachytherapy (HDR‐EBT) is mainly used as a palliative treatment modality. In this paper, we compare dosimetry distributions for a single‐channel catheter (Miami) applicator with distributions of the inflatable multichannel (Novi Sad) endorectal applicator. The comparisons were made with respect to dose coverage to the clinical tumor volume as well as to the bladder, rectal wall, prostate, and bone marrow. Our results suggest that a multichannel applicator provides better sparing of the bone marrow by 50%, clinically uninvolved parts of the rectal wall by 70%, and bladder and prostate (in the case of male patients) by 100% in terms of ratio of median doses to critical organ volume for single‐ and multichannel endorectal applicators. Our results justify the advantage of using a multichannel endorectal brachytherapy applicator as a neo‐adjuvant treatment of patients with locally advanced rectal cancer. PACS numbers: 87.53.Jw, 87.53.Tf

Collaboration


Dive into the Slobodan Devic's collaboration.

Top Co-Authors

Avatar

Ervin B. Podgorsak

McGill University Health Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Té Vuong

McGill University Health Centre

View shared research outputs
Top Co-Authors

Avatar

F DeBlois

Jewish General Hospital

View shared research outputs
Top Co-Authors

Avatar

N Tomic

McGill University Health Centre

View shared research outputs
Top Co-Authors

Avatar

Michael D.C. Evans

McGill University Health Centre

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Christopher G. Soares

National Institute of Standards and Technology

View shared research outputs
Top Co-Authors

Avatar

Belal Moftah

McGill University Health Centre

View shared research outputs
Top Co-Authors

Avatar

Carolyn R. Freeman

McGill University Health Centre

View shared research outputs
Researchain Logo
Decentralizing Knowledge